ask="5.6000"
ask_size="1300"
average_daily_volume="58117"
bid="4.3100"
bid_size="5000"
book_value="0.0000"
change="+0.0415"
change_from_200_day_moving_average="0.8366"
change_from_50_day_moving_average="0.2172"
change_from_52_week_high="-4.9085"
change_From_52_week_low="2.4415"
change_in_percent="+0.8218%"
close="5.0915"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.2650"
ebitda="0.00"
eps_estimate_current_year="-5.0600"
eps_estimate_next_quarter="-0.7000"
eps_estimate_next_year="-0.5100"
ex_dividend_date="N/A"
float_shares="N/A"
high="5.1300"
high_52_weeks="10.0000"
last_trade_date="3/13/2017"
last_trade_price="5.0915"
last_trade_size="125"
last_trade_time="3:54pm"
low="4.8800"
low_52_weeks="2.6500"
market_capitalization="N/A"
moving_average_200_day="4.2549"
moving_average_50_day="4.8743"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="6.7500"
open="5.0000"
pe_ratio="N/A"
peg_ratio="-0.0200"
percent_change_from_200_day_moving_average="+19.6612%"
percent_change_from_50_day_moving_average="+4.4562%"
percent_change_from_52_week_high="-49.0850%"
percent_change_from_52_week_low="+92.1321%"
previous_close="5.0500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="CLBS"
volume="17395"
weeks_range_52="2.6500 - 10.0000"
